Pediatric HIV Disclosure in Northern India: Evaluation of Its Prevalence, Perceptions amongst Caregivers, and Its Impact on CLHIV

Background. With improving standards of care of children living with HIV (CLHIV), pediatric HIV related mortality rates are declining. New challenges like HIV status disclosure are emerging which need to be addressed to ensure their smooth transition into adulthood. Poor disease disclosure rates are...

Full description

Bibliographic Details
Main Authors: Rajesh Meena, Alok Hemal, Shilpa Khanna Arora
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:AIDS Research and Treatment
Online Access:http://dx.doi.org/10.1155/2018/2840467
id doaj-5f1551cf434b44f6939850c70139043e
record_format Article
spelling doaj-5f1551cf434b44f6939850c70139043e2020-11-25T00:17:17ZengHindawi LimitedAIDS Research and Treatment2090-12402090-12592018-01-01201810.1155/2018/28404672840467Pediatric HIV Disclosure in Northern India: Evaluation of Its Prevalence, Perceptions amongst Caregivers, and Its Impact on CLHIVRajesh Meena0Alok Hemal1Shilpa Khanna Arora2Department of Pediatrics, Post Graduate Institute of Medical Education & Research and Dr. Ram Manohar Lohia Hospital, Baba Kharag Singh Marg, New Delhi 110001, IndiaDepartment of Pediatrics, Post Graduate Institute of Medical Education & Research and Dr. Ram Manohar Lohia Hospital, Baba Kharag Singh Marg, New Delhi 110001, IndiaDepartment of Pediatrics, Post Graduate Institute of Medical Education & Research and Dr. Ram Manohar Lohia Hospital, Baba Kharag Singh Marg, New Delhi 110001, IndiaBackground. With improving standards of care of children living with HIV (CLHIV), pediatric HIV related mortality rates are declining. New challenges like HIV status disclosure are emerging which need to be addressed to ensure their smooth transition into adulthood. Poor disease disclosure rates are observed in CLHIV globally. Aims. This study was done to assess the prevalence of HIV disclosure in North Indian CLHIV, know the perceptions of caregivers regarding disclosure, and evaluate the impact of disclosure on CLHIV. Methods. It was a questionnaire based cross-sectional study carried out amongst 144 caregivers of CLHIV aged 6-16 years attending the pediatric HIV clinic of a tertiary care teaching hospital. Results. Though the majority (93.8%) caregivers felt that it is important to disclose but only 33% of the children were actually disclosed. Eighty five percent felt that disclosure must be done by one of the family members and correspondingly 73% of the disclosed children were actually disclosed by their parents. Forty seven percent believed that the most appropriate age for disclosure is 10-12 years. The mean age at which disclosure was actually done was 11.06 ± 1.62 years. Comparison of the disclosed and undisclosed CLHIV revealed that the disclosed group had significantly higher age, longer duration of taking ART, and higher proportion of paternal orphans. Age of the CLHIV was the only significant factor for disclosure. Several reasons were cited by the caregivers for nondisclosure. The caregivers observed improved drug adherence in 47.9% of the children following disclosure. Conclusions. There is a need to develop region specific pediatric HIV disclosure guidelines keeping in mind the caregivers’ perceptions. The guidelines must be age appropriate, systematic, and socioculturally acceptable. The most suitable age for disclosure appears to be 10-12 years. Involvement of caregivers and health care providers in the process is a must.http://dx.doi.org/10.1155/2018/2840467
collection DOAJ
language English
format Article
sources DOAJ
author Rajesh Meena
Alok Hemal
Shilpa Khanna Arora
spellingShingle Rajesh Meena
Alok Hemal
Shilpa Khanna Arora
Pediatric HIV Disclosure in Northern India: Evaluation of Its Prevalence, Perceptions amongst Caregivers, and Its Impact on CLHIV
AIDS Research and Treatment
author_facet Rajesh Meena
Alok Hemal
Shilpa Khanna Arora
author_sort Rajesh Meena
title Pediatric HIV Disclosure in Northern India: Evaluation of Its Prevalence, Perceptions amongst Caregivers, and Its Impact on CLHIV
title_short Pediatric HIV Disclosure in Northern India: Evaluation of Its Prevalence, Perceptions amongst Caregivers, and Its Impact on CLHIV
title_full Pediatric HIV Disclosure in Northern India: Evaluation of Its Prevalence, Perceptions amongst Caregivers, and Its Impact on CLHIV
title_fullStr Pediatric HIV Disclosure in Northern India: Evaluation of Its Prevalence, Perceptions amongst Caregivers, and Its Impact on CLHIV
title_full_unstemmed Pediatric HIV Disclosure in Northern India: Evaluation of Its Prevalence, Perceptions amongst Caregivers, and Its Impact on CLHIV
title_sort pediatric hiv disclosure in northern india: evaluation of its prevalence, perceptions amongst caregivers, and its impact on clhiv
publisher Hindawi Limited
series AIDS Research and Treatment
issn 2090-1240
2090-1259
publishDate 2018-01-01
description Background. With improving standards of care of children living with HIV (CLHIV), pediatric HIV related mortality rates are declining. New challenges like HIV status disclosure are emerging which need to be addressed to ensure their smooth transition into adulthood. Poor disease disclosure rates are observed in CLHIV globally. Aims. This study was done to assess the prevalence of HIV disclosure in North Indian CLHIV, know the perceptions of caregivers regarding disclosure, and evaluate the impact of disclosure on CLHIV. Methods. It was a questionnaire based cross-sectional study carried out amongst 144 caregivers of CLHIV aged 6-16 years attending the pediatric HIV clinic of a tertiary care teaching hospital. Results. Though the majority (93.8%) caregivers felt that it is important to disclose but only 33% of the children were actually disclosed. Eighty five percent felt that disclosure must be done by one of the family members and correspondingly 73% of the disclosed children were actually disclosed by their parents. Forty seven percent believed that the most appropriate age for disclosure is 10-12 years. The mean age at which disclosure was actually done was 11.06 ± 1.62 years. Comparison of the disclosed and undisclosed CLHIV revealed that the disclosed group had significantly higher age, longer duration of taking ART, and higher proportion of paternal orphans. Age of the CLHIV was the only significant factor for disclosure. Several reasons were cited by the caregivers for nondisclosure. The caregivers observed improved drug adherence in 47.9% of the children following disclosure. Conclusions. There is a need to develop region specific pediatric HIV disclosure guidelines keeping in mind the caregivers’ perceptions. The guidelines must be age appropriate, systematic, and socioculturally acceptable. The most suitable age for disclosure appears to be 10-12 years. Involvement of caregivers and health care providers in the process is a must.
url http://dx.doi.org/10.1155/2018/2840467
work_keys_str_mv AT rajeshmeena pediatrichivdisclosureinnorthernindiaevaluationofitsprevalenceperceptionsamongstcaregiversanditsimpactonclhiv
AT alokhemal pediatrichivdisclosureinnorthernindiaevaluationofitsprevalenceperceptionsamongstcaregiversanditsimpactonclhiv
AT shilpakhannaarora pediatrichivdisclosureinnorthernindiaevaluationofitsprevalenceperceptionsamongstcaregiversanditsimpactonclhiv
_version_ 1725379905083932672